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Objective: Endovascular aneurysm repair (EVAR) is an increasingly used alternative to open surgical repair of unruptured
abdominal aortic aneurysms (AAAs). The effect of EVAR on postprocedure acute renal failure has not been determined.
We hypothesized that EVAR would be associated with a lower risk of acute renal failure and acute renal failure requiring
hemodialysis.
Methods: A retrospective cohort study was conducted of the 2002 Nationwide Inpatient Sample, the largest all-payer
inpatient care database in the United States, reflecting discharges from a representative sample of United States hospitals.
We identified 6614 discharges with a primary diagnosis of unruptured AAA and a primary procedure code for open AAA
repair or EVAR. We excluded 56 patients with end-stage renal disease and 42 patients who underwent concomitant
aortorenal bypass. We compared EVAR vs open repair in this cohort. The main outcomemeasures were acute renal failure
and acute renal failure requiring dialysis.
Results: A total of 6516 patient discharges met the inclusion criteria for the study, and postprocedure acute renal failure
developed in 439 (6.7%). EVAR was associated with lower odds of acute renal failure (adjusted odds ratio, 0.42; 95%
confidence interval, 0.33 to 0.53) and acute renal failure requiring dialysis (adjusted odds ratio, 0.30, 95% confidence
interval, 0.15 to 0.63). Results were similar when EVAR and open AAA repair were compared within quintiles of the
propensity score for the receipt of EVAR.
Conclusions: Compared with open AAA repair, EVAR is associated with a lower risk of postprocedure acute renal failure.
( J Vasc Surg 2006;43:460-6.)Acute renal failure (ARF) develops in 2% to 10% of
patients after open surgical abdominal aortic aneurysm
(AAA) repair1-6 and is independently associated with mor-
tality and prolonged lengths of stay after major vascular
surgery.7 Hypoperfusion related to aortic cross-clamping,
perioperative hemorrhage, and atheroembolism increase
the risk of ARF.1 ARF requiring hemodialysis has been
reported to complicate the course of 0.5% to 2% of patients
undergoing elective AAA repair,3-6,8 with associated in-
hospital mortality of 25% to 66%.3,9,10
Endovascular aortic aneurysm repair (EVAR) involves
the insertion and deployment of a stent-graft via the femo-
ral artery,11 providing a less invasive alternative to open
AAA repair. Randomized control trials comparing EVAR
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doi:10.1016/j.jvs.2005.11.053460and open repair have suggested superior short-term survival
with EVAR11,12; however, recent data have cast doubt on
the long-term advantages of EVAR.13
As outcome data on EVAR emerge, the renal implica-
tions of the procedure need to be scrutinized. Although
patients receiving EVAR are spared the ischemic insult of
aortic cross-clamping and have less perioperative hemor-
rhage,2,14 the potential nephrotoxicity of intravenous con-
trast must be considered.1,15 In addition, as in the case of
aortic surgery, manipulation of the abdominal aorta may
lead to the disruption of lipid-laden plaques and subse-
quent embolization into the renal vasculature.
To explore the differential application and outcomes of
EVAR and open surgical AAA repair in the United States,
we used data from the Nationwide Inpatient Sample (NIS),
the largest all-payer inpatient care database in the United
States. We hypothesized that EVAR would be associated
with a lower risk of ARF and ARF requiring hemodialysis.
METHODS
Database. TheNIS is a publicly available database that
forms part of the Healthcare Cost and Utilization Project
and is sponsored by the Agency for Healthcare Research
and Quality.16 The 2002 NIS contains information on
7,853,982 discharges from a 20% sample of acute care
nonfederal American hospitals in 33 states. The 995 hospi-
tals in the 2002 NIS represent a stratified probability sam-
ple with sampling probabilities proportional to the number
of hospitals in each stratum. Hospitals were stratified by
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and ownership.
The dataset provides detailed information on patient
demographics, outcomes (eg, in-hospital mortality, length
of stay), total charges, hospital characteristics, and insur-
ance status. International Classification of Diseases, 9th
edition, Clinical Modification (ICD-9-CM) codes for up to
15 diagnoses and procedures are listed for each admission.
In addition, hospital and discharge weights are provided to
extrapolate estimates to a national level and ensure that
standard errors that are used for the analyses reflect the
sampling scheme of the dataset.
Patient population. In brief, we identified all dis-
charges of patients 18 years of age with a primary diag-
nosis of an unruptured AAA (ICD-9-CM code 441.4)
where the primary procedure listed was code 38.44 for
open repair (n 3936) or 39.71 for endovascular repair (n
 2678). This strategy has been used by others.17-19 Hos-
pitalizations in which an aortorenal bypass (code 39.24)
was performed in addition to the AAA repair (n 42) were
excluded to evaluate the specific impact of the aortic pro-
cedure on kidney function. Patients receiving maintenance
dialysis (n  56) were excluded from the analysis by iden-
tifying codes associated with end-stage renal disease and
removing all discharges in which there was a dialysis code
but no concurrent diagnosis of ARF.
Exposure, outcome, and covariates. Procedure type—
EVAR vs open AAA repair—was the key exposure of inter-
est. The primary outcome was postprocedure ARF. ARF
requiring hemodialysis was also considered. ARF was iden-
tified by the presence of diagnostic codes 584.x or 997.5
and ARF requiring hemodialysis was identified by the ad-
ditional presence of a code for hemodialysis (39.95). Ad-
ministrative codes for ARF were not defined according
to conventional diagnostic criteria (ie, change in serum
creatinine). However, our efforts to validate ARF codes
indicate that the presence of an ICD-9-CM code for ARF is
associated with biochemically defined ARF in 80% of
cases.*
We evaluated patient demographic and clinical charac-
teristics that might contribute to the risk of ARF. These
included patient age,20-23 gender,24 and key comorbidities
including chronic kidney disease,3,10,20-22,24,25 diabetes
mellitus,24 chronic lung disease,25,26 congestive heart fail-
ure,25,26 and chronic liver disease.23 Each of these comor-
bidities was identified by ICD-9-CM codes based on crite-
ria described by Elixhauser et al27 (see Appendix I, online)
and modified for this analysis. The variable for chronic
kidney disease was expanded to include codes such as 593.9
(chronic renal insufficiency) but excluded codes that were
associated with end-stage renal disease. Furthermore, we
combined the Elixhauser variables for diabetes mellitus and
diabetes mellitus with complications.
*Wald et al. The identification of patients with acute renal failure using
administrative data: A validation study. American Society of Nephrology
Renal Week 2005, abstract F-P01031.We also adjusted for hospital type (rural, urban-teaching,
urban-nonteaching) and procedure volume,28 the latter
dichotomized as above and below the median number of
AAA procedures performed in a given hospital.
Statistical analyses. We compared patient character-
istics by procedure type using 2 tests for categorical vari-
ables and the Student’s t test or the Wilcoxon rank sum test
for continuous variables. Logistic regression (unadjusted,
and adjusted for multiple covariates) was used to determine
the odds ratio (OR) and 95% confidence intervals (CI)
associated with EVAR versus open AAA repair. We elected
a priori to include all demographic, clinical, and hospital-
related variables in the multivariable regression models.
Age was evaluated in quartiles to obviate a linearity assump-
tion. The Hosmer-Lemeshow goodness-of-fit 2 test was
used to assess model calibration.We considered selectedmul-
tiplicative interaction terms (eg, chronic kidney disease 
procedure type) to evaluate for effect modification.
To adjust for additional unmeasured confounding, we
fit a logistic regression model using the aforementioned
covariates with procedure type as the dependent variable.
We retained all covariates with P  .05 and generated a
propensity score for receipt of EVAR.29 The propensity
score can be used to rank individuals by the likelihood of
receiving a given treatment, so that individuals with a
similar “risk profile” can be compared. The relation be-
tween procedure type and ARF was then evaluated across
quintiles of the propensity score.
It was our expectation, based on previous studies, that
EVAR recipients would have shorter admission durations19
and that earlier discharge could reduce ascertainment of
ARF events, particularly ARF not requiring hemodialysis.
To determine the potential influence of early discharge on
the ARF risk estimates, we performed a sensitivity analysis
where we assigned ARF events to a variable fraction of
EVAR recipients discharged 2 days using modified pre-
dicted risk estimates from the vector of nonoperative co-
variates.
Two-tailed P values of .05 were considered statisti-
cally significant. All statistical procedures were done using
SAS version 9.1.3 (SAS Institute, Cary, NC) and SAS-
callable SUDAAN version 9.0 (Research Triangle Institute,
Research Triangle Park, NC). SUDAAN was used to con-
duct analyses that account for the complex sampling
scheme of the NIS.30
RESULTS
Among 6516 discharges that met the inclusion criteria,
3865 (59.3%) were for open AAA repair and 2651 (40.7%)
were for EVAR. Patients receiving EVAR were older, more
likely to be male and to be diagnosed with diabetes melli-
tus, but were less likely to have pre-existing congestive
heart failure or chronic lung disease (Table I).
Discharges occurred across 412 hospitals. Both proce-
dure types were performed at 222 of the hospitals encom-
passing 5573 of the admissions; 177 sites performed open
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sions) performed only EVAR. The median number of
procedures per hospital was eight. Most procedures (89%)
were done in centers whose volume exceeded the median.
EVAR and open repair tended to be performed in different
settings (Table I). The most common venue for the perfor-
mance of both procedures was an urban teaching hospital,
although the proportion of cases performed in these hospi-
tals was substantially higher for EVAR compared with open
surgical repair (64% vs 49%). Similarly, the proportion of
procedures performed at urban nonteaching and rural hos-
pitals was lower in the EVAR group.
Table I. Comparison of patients by type of abdominal aor
Variable
Open repair
(n  3865)
Mean age in years  SD 71.6  10.8
Female (%) 889 (23.0)
Chronic kidney disease (%) 326 (8.4)
Congestive heart failure (%) 448 (11.6)
Chronic lung disease (%) 1417 (36.7)
Chronic liver disease (%) 40 (1.0)
Diabetes mellitus (%) 398 (10.3)
Hospital type (%)*
Rural 252 (6.5)
Urban nonteaching 1723 (44.6)
Urban teaching 1,887 (48.8)
Hospital volume (%)
Low 572 (14.8)
High 3293 (85.2)
EVAR, Endovascular aneurysm repair.
*Hospital type not available for 3 admissions.
Table II. Univariate and multivariate predictors of postpr
abdominal aortic aneurysm repair
Predictor
Number of admissio
(n  6516)
Endovascular repair (%) 2651 (40.7)
Age (years)
Youngest quartile (23-67) 1688 (25.9)
Second quartile (68-73) 1697 (26.0)
Third quartile (74-78) 1646 (25.3)
Fourth quartile (79-94) 1485 (22.8)
Female gender (%) 1279 (19.6)
Chronic kidney disease (%) 520 (8.0)
Congestive heart failure (%) 639 (9.8)
Chronic lung disease (%) 2233 (34.3)
Chronic liver disease (%) 58 (0.9)
Diabetes mellitus (%) 757 (11.6)
Hospital type* (%)
Rural 391 (6.0)
Urban nonteaching 2,548 (39.1)
Urban teaching 3,574 (54.9)
Hospital volume (%)
Low 700 (10.7)
High 5,816 (89.3)
OR, Odds ratio; CI, confidence interval.
*Hospital type not available for 3 admissions.ARFwas diagnosed on 439 (6.7%) admissions. Table II
presents relations among procedure type, covariates, and
the development of ARF. Endovascular aortic repair was
inversely associated with the development of ARF (OR,
0.41; 95% CI, 0.33 to 0.52). Older age and female gender
were significantly associated with ARF, as were the presence
of chronic kidney disease, congestive heart failure, and
chronic lung disease. When adjusted for covariates, the
association between EVAR and the risk of ARF remained
significant (OR, 0.42; 95% CI, 0.33 to 0.53).
ARF requiring hemodialysis occurred on 56 admissions
(0.87% of all admissions). As summarized in Table III,
neurysm repair
EVAR
(n  2651) P
73.5  10.4 .0001
390 (14.7) .0001
194 (7.3) .15
191 (7.2) .0001
816 (30.8) .0001
18 (0.7) .15
359 (13.5) .0002
139 (5.2) .0001
825 (31.1)
1,687 (63.6)
128 (4.8) .0001
2523 (95.2)
ure acute renal failure among patients undergoing
Unadjusted OR
(95% CI)
Adjusted OR
(95% CI)
0.41 (0.33-0.52) 0.42 (0.33-0.53)
1 1
1.28 (0.90-1.81) 1.18 (0.84-1.67)
1.87 (1.34-2.60) 1.61 (1.16-2.24)
1.90 (1.40-2.59) 1.76 (1.27-2.43)
1.38 (1.10-1.73) 1.24 (0.98-1.56)
6.24 (4.91-7.94) 5.78 (4.49-7.43)
2.72 (2.12-3.50) 2.31 (1.79-2.99)
1.34 (1.08-1.66) 1.11 (0.88-1.38)
2.08 (0.82-5.25) 2.20 (0.79-6.08)
0.90 (0.64-1.27) 0.88 (0.62-1.26)
1 1
0.75 (0.51-1.08) 0.64 (0.43-0.96)
0.76 (0.52-1.10) 0.76 (0.51-1.13)
1 1
0.77 (0.56-1.06) 0.96 (0.69-1.35)tic aoced
ns
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dure dialysis (crude OR, 0.27; 95% CI, 0.13 to 0.54 and
adjusted OR, 0.30; 95% CI, 0.15 to 0.63).
These models were well fit (Hosmer-Lemeshow 2 P
.34 for the adjusted ARF and P  .38 for ARF requiring
dialysis models).
We fit a propensity score for the receipt of EVAR by
using a multivariable logistic regression model. The inverse
association between EVAR and postprocedure ARF was
evident within each propensity score quintile (Table IV).
We evaluated whether the risk of ARF by procedure
type depended on the presence or absence of underlying
chronic kidney disease. The relative odds of ARF with
EVAR were lower among patients without chronic kidney
disease compared to those with chronic kidney disease
(OR, 0.37; 95% CI, 0.27 to 0.49 vs OR, 0.58; 95% CI,
0.38 to 0.90) although the interaction was not statistically
Table III. Univariate and multivariate predictors of post-p
patients undergoing abdominal aortic aneurysm repair
Predictor
Number of admissio
(n  6516)
Endovascular repair (%) 2,651 (40.7)
Age (years)
Youngest quartile (23-67) 1688 (25.9)
Second quartile (68-73) 1697 (26.0)
Third quartile (74-78) 1646 (25.3)
Fourth quartile (79-94) 1485 (22.8)
Female gender (%) 1279 (19.6)
Chronic kidney disease (%) 520 (8.0)
Congestive heart failure (%) 639 (9.8)
Chronic lung disease (%) 2233 (34.3)
Chronic liver disease* (%) 58 (0.9)
Diabetes mellitus (%) 757 (11.6)
Hospital type† (%)
Rural 391 (6.0)
Urban non-teaching 2548 (39.1)
Urban teaching 3574 (54.9)
Hospital volume (%)
Low 700 (10.7)
High 5816 (89.3)
OR, Odds ratio; CI, Confidence interval.
*No patients with chronic liver disease developed acute renal failure requiri
†Hospital type not available for 3 admissions.
Table IV. Propensity score analysis
Propensity score
quintile
Open repair
(%)
EVAR
(%)
OR of ARF
(95% CI)
1 (n  1289) 1009 (78.4) 278 (21.6) 0.48 (0.37-0.61)
2 (n  1315) 870 (66.2) 445 (33.8) 0.36 (0.28-0.46)
3 (n  1135) 624 (55.5) 511 (45.0) 0.49 (0.39-0.62)
4 (n  1365) 747 (54.7) 618 (45.3) 0.33 (0.25-0.43)
5 (n 1411) 612 (43.4) 799 (56.6) 0.59 (0.48-0.73)
EVAR, Endovascular aneurysm repair; OR, odds ratio; CI, confidence
interval; ARF, acute renal failure.
A propensity score was developed based on a logistic regression model
predicting the likelihood of receiving EVAR. The impact of EVAR on
postprocedure ARF is shown within each propensity score quintile; each
quintile contains varying proportions of surgical and EVAR patients.significant (P .074). Other interactions (eg, procedure
age, procedure  gender, procedure  diabetes) were not
statistically significant (data not shown), suggesting a uni-
formly lower risk of ARF with EVAR.
The median length of stay was 7 days among patients
who underwent open AAA repair and 2 days among pa-
tients who received EVAR. To address potential under-
ascertainment of ARF among EVAR recipients owing to
their shorter lengths of stay, we performed a sensitivity
analysis whereby EVAR patients with lengths of stay of2
days were assigned outcomes of ARF in varying propor-
tions. As presented in Table V, the rate of undocumented
ARF among EVAR recipients with short lengths of stay
would have to be at least 6% for the inverse association
between EVAR and ARF to lose statistical significance.
There were 173 (2.7%) postoperative deaths. Mortality
was higher among patients who underwent open repair
compared with EVAR (3.9% vs 1%, P .0001). In-hospital
mortality was markedly higher among patients who devel-
oped ARF compared with those who did not (18.9% vs
1.6%, P  .0001). After adjustment for procedure type,
demographic factors, comorbidity, and hospital related fac-
tors, ARF remained independently associated with mortal-
ity (OR, 11.3; 95% CI, 7.6 to 16.8). The association of
ARF with mortality did not differ by procedure type (P 
.42 for interaction term).
DISCUSSION
In a nationally representative cohort of patients under-
going AAA repair, EVAR was associated with a 60% reduc-
tion in the risk of postprocedure ARF. The protective effect
of EVAR was evident among patients with and without
dure acute renal failure requiring hemodialysis among
Unadjusted OR
(95% CI)
AdjustedOR
(95% CI)
0.27 (0.13-0.54) 0.30 (0.15-0.63)
1 1
1.03 (0.43-2.47) 0.88 (0.36-2.14)
1.73 (0.78-3.83) 1.32 (0.57-3.05)
1.26 (0.53-2.99) 0.97 (0.39-2.41)
1.37 (0.70-2.66) 1.23 (0.60-2.51)
5.39 (3.07-9.47) 4.49 (2.51-8.05)
4.77 (2.78-8.20) 4.20 (2.37-7.44)
1.22 (0.68-2.10) 0.84 (0.46-1.55)
— —
0.88 (0.33-2.38) 0.85 (0.31-2.34)
1 1
1.10 (0.33-3.60) 1.01 (0.29-3.52)
1.17 (0.37-3.67) 1.50 (0.41-5.45)
1 1
0.46 (0.24-0.87) 0.52 (0.25-1.08)
modialysis.roce
ns
ng he
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required for ARF. These findings should provide a degree
of reassurance to physicians struggling with the relative
renal safety of alternative AAA repair modalities and con-
firms the observations of others.15,31,32 Although our anal-
ysis involves nonrandomized data, the scope of the NIS
database is such that our results are a reflection of the
outcomes of contemporary practice across the United
States. Moreover, our access to extensive demographic,
comorbidity, and hospital data in the NIS enabled us to
evaluate the association of procedure type with ARF inci-
dence while adjusting for potential confounders.
The findings reported here may help to clarify conflict-
ing results from other observational studies and clinical
trials. The Dutch Randomized Endovascular Aneurysm
Management (DREAM) trial showed that postoperative
changes in serum creatinine levels were similar in patients
undergoing EVAR and open AAA repair.12 However, en-
rolment in this randomized trial was limited to centers that
performed at least 30 open AAA repairs and 50 EVAR
procedures annually.33 In addition, the patient population
in the DREAM study was younger, included fewer women,
and had a lower frequency of some comorbidities, includ-
ing diabetes and chronic lung disease, compared with the
cohort we have described.
In their systematic review, Adriaensen et al2 showed
that the incidence of short-term kidney injury was lower in
patients undergoing EVAR compared with open AAA re-
pair. In a nonrandomized study comparing EVAR and
open AAA repair, Greenberg et al1 found that the propor-
tion of patients with a30% increase in serum creatinine at
discharge was lower among EVAR recipients, but kidney
function was comparable between the treatment groups at
1 year. A recent study from the National Surgical Quality
Improvement Program failed to demonstrate a significant
difference in the rate of postprocedural ARF between the
Table V. Results of sensitivity analysis
Patients
with ARF
(real  imputed)
Adjusted OR for
procedure type
(95% CI)
Actual data 439 0.42 (0.33-0.53)
Rate of postdischarge ARF
5% 512 0.75 (0.61-0.91)
6% 526 0.82 (0.67-1.01)
7% 540 0.92 (0.75-1.13)
8% 555 1.02 (0.82-1.27)
9% 569 1.12 (0.90-1.38)
10% 584 1.20 (0.97-1.49)
11% 598 1.30 (1.06-1.60)
12% 612 1.40 (1.14-1.72)
ARF, acute renal failure; OR, odds ratio; CI, confidence interval
Adjusted ORs for the development of ARF after accounting for the hypo-
thetical development of postdischarge ARF among endovascular aneurysm
repair (EVAR) patients discharged from within hospital 2 days. The first
row represents actual data from the cohort followed by scenarios in which
additional cases of ARF developed among EVAR recipients with short
lengths of stay.surgical and EVAR groups,6 However, the latter three
studies did not adjust for potential confounders of the
relationship between procedure type and ARF.
Great lengths were taken to ensure that all clinically
relevant confounders were included in our models, but
residual confounding may still be present. The inverse
association between EVAR and ARF that we demonstrated
may be due in part to referral of patients for open repair
who were at higher risk for ARF (ie, selection bias). We
believe this is unlikely, because patients who underwent
EVAR were older and were more likely to have diabetes,
two well-established risk factors for postoperative ARF.
Patient eligibility for EVAR is tied to the technical
feasibility of the procedure. This may skew the relative risk
of postprocedure ARF, as patients with anatomically chal-
lenging aneurysms may be more likely to receive open
repair. For example, juxtarenal aneurysms, which may be
associated with a higher rate of postprocedure ARF, are
more likely to have been repaired by open methods.34
Because the NIS is an administrative data source, we could
not adjust for confounding by aneurysm location or struc-
ture.
Information bias is another important limitation of this
study. The ascertainment of ARF is particularly susceptible
to misclassification. Central to this problem is the absence
of a universally accepted definition for ARF.35 The lack of
clear criteria for the assignment of an ARF diagnosis (and a
subsequent diagnostic code for ARF) leads to a situation
where coding practices, rather than clinical reality, may
guide the inclusion of ARF in a discharge summary. This
source of information bias is likely nondifferential, be-
cause there is no reason to expect that the accuracy of
ARF coding should differ between the procedure types.
Nondifferential misclassification would bias the association
toward the null. It is also reassuring that the rate of ARF in
patients undergoing open AAA repair was similar to that
reported in previous series.1-4 Finally, since the administra-
tion of hemodialysis for ARF is unlikely to be coded inac-
curately, it is notable that the protective effect of EVAR on
the outcome of ARF requiring hemodialysis paralleled the
impact of procedure type on the development of ARF
overall.
A further source of differential information bias is
rooted in the differing lengths of stay in the two groups.
Given amarkedly shorter length of stay in the EVAR group,
it is conceivable that clinical evidence of acute kidney injury
developed after discharge in some EVAR patients, which
would not be captured in this database. As contrast ne-
phropathy usually becomes apparent within 24 to 48 hours
of the procedure,36 under-ascertainment of ARF among
EVAR recipients whose length of stay was 2 days may
have occurred. Unfortunately, the NIS does not permit the
assessment of postdischarge data and because each dis-
charge—rather than the actual patient—is assigned a spe-
cific identifier, information on readmissions for ARF would
be unobtainable. However, we estimated that among
EVAR patients discharged within 2 days, ARF incidence
would have to surpass 5% for EVAR to lose its relative
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for post-EVAR ARF,6,15 it is unlikely that this form of
misclassification would be substantial enough for the in-
verse association between EVAR and ARF to be lost.
CONCLUSION
This study provides important information on the renal
safety of a novel approach to the repair of AAAs. Compared
with open AAA repair, our findings suggest that EVAR is
associated with a lower risk of postprocedure ARF. These
results reflect the outcomes of actual practice in a hetero-
geneous and unselected patient population that received
care in a wide spectrum of hospitals. As EVAR becomes a
more widely practiced procedure, strategies to further re-
duce procedure-related kidney injury should be diligently
investigated.
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An increasedmortality risk is associated with acute renal failure
(ARF) complicating abdominal aortic aneurysm (AAA) repair re-
gardless of supportive therapy. Consequently, it is imperative to
select treatment options that minimize this complication. Wald
et al provide a well-conceived report that uses the Nationwide
Inpatient Sample (NIS) to compare the incidence of ARF associ-
ated with open AAA and endovascular aortic aneurysm repair
(EVAR). Many of the study weaknesses are acknowledged, and some
are addressed by the authors’ statistical analysis. However, the single
greatest weakness—limitations posed by the NIS database—cannot
be fully addressed.
The NIS is inadequate to account for critically important
cofounders relevant to the question of comparable ARF risk for
open AAA repair and EVAR. Patient-specific information pertain-
ing to aneurysm anatomy is not provided by the database. As a
result, no adjustments can be made for aneurysm location or
structure. An increased incidence of chronic lung disease and heart
failure among patients submitted to open AAA repair suggest that
procedure selection was made on the basis of anatomic criteria
favorable for EVAR. Selection bias for open repair may have
included juxtarenal/suprarenal AAAs with well-recognized risk
factors for ARF—suprarenal or extended aortic cross-clamp asso-
ciated with increased blood loss. Moreover, the NIS does not
provide patient-specific information regarding readmission for
ARF. The authors suggest that deterioration in renal function
secondary to contrast nephropathy with EVAR would be recog-
nized within 24 to 48 hours. However, a decrease in the glomer-ular filtration rate may not be detected among patients with
baseline serum creatinine within the normal range. In particular,
renal function decline due to atheroembolism may escape detec-
tion during this time frame.
The authors attempt to account for unmeasured confounding
covariates through generation of a propensity score for receipt of
EVAR. Although appropriate and useful, the propensity score
controls for only observed covariates.1 Only prospective random-
ization controls for both observed and unobserved covariates. In
this latter regard, the Dutch Randomized Endovascular Aneurysm
Management (DREAM) Trial Group observed an equal ARF risk
for open AAA repair and EVAR.2 Although this trial required
participating centers to have high volumes in both open AAA
repair and EVAR, it should be considered the best comparison of
relative renal risk associated with these procedures. Because of
uncorrectable residual confounding associated with selection and
information bias, the findings of this well-written article provide a
measure of reassurance regarding ARF risk associated with EVAR,
but the findings cannot be considered conclusive.
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Cohort assembly
Primary diagnosis code of unruptured abdominal aortic aneurysm (AAA):
441.4, abdominal aortic aneurysm without mention of rupture
AND
Primary procedure code of open AAA repair or endovascular repair of aortic aneurysm (EVAR):
38.44, resection of vessel with replacement (aorta, abdominal)
OR
39.71, endovascular implantation of graft in abdominal aorta
Excluded:
● concomitant renovascular surgery: 39.24 (aorta-renal bypass)
● patients with end-stage renal disease:
V45.1, renal dialysis status
V56.0, extracorporeal dialysis; dialysis (renal) not otherwise specified
V56.8, other dialysis; peritoneal dialysis
39.95, hemodialysis with chronic kidney disease (CKD) code but no concomitant code for acute renal failure (ARF) (see below for
ARF and CKD codes)
Outcomes
Acute renal failure:
584.5, acute renal failure with lesion of acute tubular necrosis
584.6, acute renal failure with lesion of renal cortical necrosis
584.7, acute renal failure with lesion of renal medullary (papillary) necrosis
584.8, acute renal failure with other specified pathological lesion in kidney
584.9, acute renal failure, unspecified
997.5, urinary complications of surgical care (including ARF due to procedure, acute renal insufficiency specified as due to
procedure, acute tubular necrosis specified as due to procedure)
Acute renal failure requiring hemodialysis:
ARF as above  procedure code for hemodialysis (39.95)
Comorbidities
Chronic kidney disease:
403.xx, hypertensive renal disease
404.xx, hypertensive heart and renal disease
581.xx, nephrotic syndrome
582.xx, chronic glomerulonephritis
583.xx, nephritis or nephropathy, not specified as acute or chronic
585, chronic renal failure, chronic uremia
586, renal failure, unspecified
593.9, unspecified disorder of kidney and ureter (includes renal disease (chronic) not otherwise specified)
Chronic liver disease:
070.22, chronic viral hepatitis B with hepatic coma
070.23, chronic viral hepatitis B with hepatitis delta with hepatic coma
070.32, chronic viral hepatitis B without mention of hepatic coma
070.33, chronic viral hepatitis B with hepatitis delta without mention of hepatic coma
070.44, chronic hepatitis C with hepatic coma
070.54, chronic hepatitis C without mention of hepatic coma
456.0, esophageal varices with bleeding
456.1, esophageal varices without mention of bleeding
456.20, esophageal varices in diseases classified elsewhere, with bleeding
456.21, esophageal varices in diseases classified elsewhere, without mention of bleeding
571.0, alcoholic fatty liver
571.2, alcoholic cirrhosis of liver
571.3, alcoholic liver damage, unspecified
571.40-571.49, chronic hepatitis (non-viral)
571.5, cirrhosis of liver without mention of alcohol
571.6, biliary cirrhosis
571.8, other chronic non-alcoholic liver disease
571.9, unspecified chronic liver disease without mention of alcohol
572.3, portal hypertension
572.8, other sequelae of chronic liver disease
V42.7, liver transplant
Chronic pulmonary disease:
490, bronchitis not specified as acute or chronic
491.xx, obstructive chronic bronchitis
492.x, emphysema
493.xx, asthma
494.x-, bronchiectasis
495.x, extrinsic allergic alveolitis
496, chronic airway obstruction, not elsewhere classified
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500, coal workers’ pneumoconiosis
501, asbestosis
502, pneumoconiosis due to other silica or silicates
503, pneumoconiosis due to other inorganic dust
504, pneumonopathy due to inhalation of other dust
505, pneumoconiosis unspecified
506.4, chronic respiratory conditions due to fumes or vapors
Congestive heart failure:
398.91, rheumatic heart failure (congestive)
402.01, malignant hypertensive heart disease with heart failure
402.11, benign hypertensive heart disease with heart failure
402.91, unspecified hypertensive heart disease with heart failure
404.01, malignant hypertensive heart and renal disease with heart failure
404.03, malignant hypertensive heart and renal disease with heart failure and renal failure
404.11, benign hypertensive heart and renal disease with heart failure
404.13, benign hypertensive heart and renal disease with heart failure and renal failure
404.91, unspecified hypertensive heart and renal disease with heart failure
404.93, unspecified hypertensive heart and renal disease with heart failure and renal failure
428.xx, heart failure
Diabetes mellitus:
250.xx, diabetes mellitus (with various complications)
